Kuangli Bio-Tech Holdings Co., Ltd. (TPE:6431)
Taiwan · Delayed Price · Currency is TWD 21.30
+0.25 (1.19%)
Apr 17, 2026, 1:30 PM CST
Kuangli Bio-Tech Holdings Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -192.98 | -172.79 | -104.16 | -68.72 | 25.84 |
Depreciation & Amortization | 86.61 | 83.65 | 60.38 | 60.48 | 39.58 |
Other Amortization | 0.27 | 0.27 | 0.27 | 0.27 | 0.33 |
Loss (Gain) From Sale of Assets | -0.01 | - | - | -0.15 | -64.27 |
Asset Writedown & Restructuring Costs | 8.39 | 26.01 | 9.17 | - | - |
Loss (Gain) on Equity Investments | - | - | - | - | -10.92 |
Provision & Write-off of Bad Debts | 8.86 | 6.98 | -0.75 | 0.25 | -4.4 |
Other Operating Activities | 8.88 | -5.65 | -22.1 | -12.76 | 31.34 |
Change in Accounts Receivable | 7.77 | -35.72 | 27.8 | 35.43 | 55.64 |
Change in Inventory | 10.91 | -12 | 17.47 | 32.96 | -11.36 |
Change in Accounts Payable | -7.37 | 34.18 | -7.31 | -64.57 | -7.49 |
Change in Unearned Revenue | 13.3 | 5.89 | -1.91 | -0.12 | -13.28 |
Change in Other Net Operating Assets | -89.96 | 3.95 | -41.23 | 8.33 | -9.46 |
Operating Cash Flow | -145.33 | -65.23 | -62.36 | -9.24 | 21.69 |
Operating Cash Flow Growth | - | - | - | - | 155.27% |
Capital Expenditures | -9.32 | -12.44 | -25.21 | -34.22 | -40.36 |
Sale of Property, Plant & Equipment | 0.03 | 2.21 | - | 2.83 | 6.76 |
Cash Acquisitions | - | - | - | - | 41.82 |
Divestitures | - | - | - | -1.34 | 8.6 |
Sale (Purchase) of Intangibles | - | -5 | - | - | -0.24 |
Investment in Securities | -3 | 27.62 | -6.57 | - | -111.49 |
Other Investing Activities | 22.94 | 46.44 | -0.81 | 29.57 | 1.46 |
Investing Cash Flow | 14.07 | 62.25 | -30.51 | -3.16 | -93.45 |
Short-Term Debt Issued | 256.38 | 222.2 | 219.18 | 95.83 | - |
Long-Term Debt Issued | 10 | 20 | 41.37 | 22.1 | - |
Total Debt Issued | 266.38 | 242.2 | 260.55 | 117.92 | - |
Short-Term Debt Repaid | -214.62 | -235.23 | -218.12 | -97.28 | -4.38 |
Long-Term Debt Repaid | -61.32 | -78.91 | -25.06 | -31.95 | -26.7 |
Total Debt Repaid | -275.94 | -314.13 | -243.19 | -129.23 | -31.07 |
Net Debt Issued (Repaid) | -9.55 | -71.93 | 17.37 | -11.31 | -31.07 |
Issuance of Common Stock | 320.6 | 55.34 | - | 353.22 | 145.71 |
Other Financing Activities | 3.01 | 0.52 | 0.16 | -352.98 | 6.38 |
Financing Cash Flow | 314.06 | -16.07 | 17.52 | -11.07 | 121.01 |
Foreign Exchange Rate Adjustments | -15.46 | -2.57 | -3.32 | 3.19 | -1.51 |
Net Cash Flow | 167.34 | -21.63 | -78.67 | -20.28 | 47.74 |
Free Cash Flow | -154.65 | -77.68 | -87.58 | -43.46 | -18.67 |
Free Cash Flow Margin | -41.02% | -20.37% | -29.85% | -12.70% | -5.61% |
Free Cash Flow Per Share | -1.66 | -1.13 | -1.53 | -0.77 | -0.37 |
Cash Interest Paid | 4.66 | 8.46 | 7.09 | 7.71 | 4.09 |
Cash Income Tax Paid | -0.09 | 1.33 | 2.91 | 2.28 | 6.35 |
Levered Free Cash Flow | -70.02 | 41.09 | -51.57 | 1.94 | -203.89 |
Unlevered Free Cash Flow | -61.46 | 51.01 | -42.71 | 10.87 | -198.76 |
Change in Working Capital | -65.36 | -3.7 | -5.16 | 12.02 | 14.05 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.